Skip to search formSkip to main contentSkip to account menu

Copaxone

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Glatiramer acetate is indicated for the treatment of patients with relapsing forms of multiple sclerosis (RMS). In 2016, an… 
2013
2013
Background: Glatiramer acetate (GA, Copaxone®), a mixture of polymers comprising four amino acids, is approved for treatment of… 
2011
2011
ized pruritic exanthema over the whole body immediately after injection of Copaxone. This improved after a few days without… 
2011
2011
A complex association analysis of copaxone (glatiramer acetate) immunotherapy efficacy with allelic polymorphism of the number of… 
2008
2008
Background: Copaxone (glatiramer acetate) is a synthetic copolymer mimicking a portion of myelin basic protein, one of several… 
2007
2007
The hallmark of prion disease‐induced neurodegeneration is the accumulation of PrPSc, a misfolded form of PrPC. In addition… 
2001
2001
To the Editor: I enthusiastically agree with the conclusion reached by Drs. Schwid and Bever: “that foregoing MS treatment, even…